These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Experimental transplant arteriosclerosis: inhibition by angiopeptin and low molecular weight heparin derivatives. Akyürek ML; Larsson E; Funa K; Wanders A; Kaijser M; Fellström BC Transplant Proc; 1995 Dec; 27(6):3555-6. PubMed ID: 8540099 [No Abstract] [Full Text] [Related]
8. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection. Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115 [No Abstract] [Full Text] [Related]
9. Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue. Lundergan CF; Foegh ML; Ramwell PW J Am Coll Cardiol; 1991 May; 17(6 Suppl B):132B-136B. PubMed ID: 1673136 [TBL] [Abstract][Full Text] [Related]
10. Effect of angiopeptin and aspirin on accelerated graft atherosclerosis in transplanted mouse heart. Lee JR; Yang JH; Kim EK; Seo JW J Korean Med Sci; 1999 Dec; 14(6):607-12. PubMed ID: 10642937 [TBL] [Abstract][Full Text] [Related]
12. Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? Shibata T; Ogawa N; Koyama I; Ksaneko N; Hokazono K; Omoto R Transplant Proc; 1993 Feb; 25(1 Pt 2):1145-8. PubMed ID: 7680147 [No Abstract] [Full Text] [Related]
14. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Paul LC; Hayry P; Foegh M; Dennis MJ; Mihatsch MJ; Larsson E; Fellström B Transplant Proc; 1993 Apr; 25(2):2022-3. PubMed ID: 8470261 [No Abstract] [Full Text] [Related]
15. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619. Zhao Y; Foegh ML Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208 [TBL] [Abstract][Full Text] [Related]
16. Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog. Wahlers T; Mügge A; Oppelt P; Heublein B; Fieguth HG; Jurmann M; Haverich A Transplant Proc; 1994 Oct; 26(5):2741-2. PubMed ID: 7940860 [No Abstract] [Full Text] [Related]
17. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425 [No Abstract] [Full Text] [Related]
18. Coronary arteriopathy postcardiac transplant in a heterotopic piglet model: the role of matrix-cytokine interaction. Clausell N; Coles J; Rabinovitch M Transplant Proc; 1993 Feb; 25(1 Pt 2):859-60. PubMed ID: 8442248 [No Abstract] [Full Text] [Related]
19. Short-term angiopeptin therapy and the incidence of graft vessel disease after heart transplantation. Meiser BM; Mueller M; Foegh M; Von Scheidt W; Reichart B J Heart Lung Transplant; 2002 Dec; 21(12):1264-73. PubMed ID: 12490271 [TBL] [Abstract][Full Text] [Related]
20. Endothelialitis in accelerated allograft arteriosclerosis in human cardiac transplant recipients. Paavonen T; Mennander A; Lautenschlager I; Häyry P Transplant Proc; 1992 Feb; 24(1):342-3. PubMed ID: 1539307 [No Abstract] [Full Text] [Related] [Next] [New Search]